Dongxiao Shen

Dongxiao Shen

Auto-generated profile, based on publicly available information

Dongxiao Shen

Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2022 in Science Advances
Verified
Journal Article
Open access
DKDaniel H. Katz
Daniel H. Katz
JRJeremy M. Robbins
Jeremy M. Robbins
SDShuliang Deng
Shuliang Deng
UTUsman A. Tahir
Usman A. Tahir
ABAlexander G. Bick
Alexander G. Bick
RGRobert Edgardo Gerszten
Robert Edgardo Gerszten
High-throughput proteomic profiling using antibody or aptamer-based affinity reagents is used increasingly in human studies. However, direct analyses to address the relative strengths and weaknesses of these platforms are lacking. We assessed findings from the SomaScan1.3K ( N = 1301 reagents), the SomaScan5K platform ( N = 4979 reagents), and the Olink Explore ( N = 1472 reagents) profiling techniques in 568 adults from the Jackson Heart Study and 219 participants in the HERITAGE Family Study across four performance domains: precision, accuracy, analytic breadth, and phenotypic associations leveraging detailed clinical phenotyping and genetic data. Across these studies, we show evidence supporting more reliable protein target specificity and a higher number of phenotypic associations for the Olink platform, while the Soma platforms benefit from greater measurement precision and analytic breadth across the proteome.

21 May 2021 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
PDF file
DKDaniel H. Katz
Daniel H. Katz
UTUsman A. Tahir
Usman A. Tahir
DNDebby Ngo
Debby Ngo
MBMark D. Benson
Mark D. Benson
YGYan Gao
Yan Gao
RGRobert Edgardo Gerszten
Robert Edgardo Gerszten
Background: Increased left ventricular (LV) mass is associated with adverse cardiovascular events including heart failure (HF). Both increased LV mass and HF disproportionately affect Black individuals. To understand the underlying mechanisms, we undertook a proteomic screen in a Black cohort and compared the findings to results from a White cohort. Methods: We measured 1305 plasma proteins using the SomaScan platform in 1772 Black participants (mean age, 56 years; 62% women) in JHS (Jackson Heart Study) with LV mass assessed by 2-dimensional echocardiography. Incident HF was assessed in 1600 participants. We then compared protein associations in JHS to those observed in White participants from FHS (Framingham Heart Study; mean age, 54 years; 56% women). Results: In JHS, there were 110 proteins associated with LV mass and 13 proteins associated with incident HF hospitalization with false discovery rate <5% after multivariable adjustment. Several proteins showed expected associations with both LV mass and HF, including NT-proBNP (N-terminal pro-B-type natriuretic peptide; β=0.04; P =2×10 −8 ; hazard ratio, 1.48; P =0.0001). The strongest association with LV mass was novel: LKHA4 (leukotriene-A4 hydrolase; β=0.05; P =5×10 −15 ). This association was confirmed on an alternate proteomics platform and further supported by related metabolomic data. Fractalkine/CX3CL1 (C-X3-C Motif Chemokine Ligand 1) showed a novel association with incident HF (hazard ratio, 1.32; P =0.0002). While established biomarkers such as cystatin C and NT-proBNP showed consistent associations in Black and White individuals, LKHA4 and fractalkine were significantly different between the two groups. Conclusions: We identified several novel biological pathways specific to Black adults hypothesized to contribute to the pathophysiologic cascade of LV hypertrophy and incident HF including LKHA4 and fractalkine.

28 April 2022 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
DKDaniel H. Katz
Daniel H. Katz
GJGinger Jiang
Ginger Jiang
LFLaurie A. Farrell
Laurie A. Farrell
DSDongxiao Shen
Dongxiao Shen
CAChristina L. Aquilante
Christina L. Aquilante
RGRobert Edgardo Gerszten
Robert Edgardo Gerszten